TITLE

Therapeutic lifestyle and disease-management interventions: pushing the scientific envelope

AUTHOR(S)
Alter, David A.
PUB. DATE
October 2007
SOURCE
CMAJ: Canadian Medical Association Journal;10/9/2007, Vol. 177 Issue 8, p887
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
The article presents a perspective on variation in the results of studies of therapeutic lifestyle and disease management interventions. With this, programs that are more comprehensive, flexible, personalized and intensively supported by trained, experienced health care professionals can be expected to have greater efficacy. Such interventions may require more rigorous and creative risk-stratification techniques based not only on predictors of adverse outcomes.
ACCESSION #
26756571

 

Related Articles

  • Getting Better All the Time. Solz, Heidi // Health Management Technology;Sep2001, Vol. 22 Issue 9, p42 

    Reports that emerging technologies can strengthen operations of disease management (DM) programs for managed care organizations (MCO). Key factors in developing and implementing a DM program; Strategies for achieving savings through DM; Advantages of artificial intelligence features on the DM...

  • Disease management: Elements of disease management.  // Pharmaceutical Representative;Jul2008, Vol. 13 Issue 7, p28 

    The article discusses the elements of disease management including the identification of patient groups at risk, application of therapeutic interventions and measurement of outcomes achieved by intervention. Identification of patient demographics or member population is considered to be the...

  • Getting Patients to Follow Treatment Plans is Challenging, Costly. Ament, Lucy // H&HN: Hospitals & Health Networks;Apr2008, Vol. 82 Issue 4, p16 

    The article discusses the problem of poor patient adherance to diseases managemet protocol in the U.S. The question of whether to create disease management programs to help patients with chronic conditions is a frustrating one for health care administrators. Sherrie Kaplan, associate dean of the...

  • The Effect of a Disease Management Intervention on Quality and Outcomes of Dementia Care. Vickrey, Barbara G.; Mittman, Brian S.; Connor, Karen I.; Pearson, Marjorie L.; Della Penna, Richard D.; Ganiats, Theodore G.; DeMonte Jr., Robert W.; Chodosh, Joshua; Xinping Cui; Vassar, Stefanie; Naihua Duan; Lee, Martin // Annals of Internal Medicine;11/21/2006, Vol. 145 Issue 10, p713 

    Background: Adherence to dementia guidelines is poor despite evidence that some guideline recommendations can improve symptoms and delay institutionalization of patients. Objective: To test the effectiveness of a dementia guideline-based disease management program on quality of care and outcomes...

  • Employers focus on cost control for health savings. Prince, Michael // Business Insurance;7/7/2003, Vol. 37 Issue 27, p20 

    To rein in rising health care costs, more employers are turning to where the big expenses are. More than in past years, employers in 2003 are adding disease management programs to their toolbox of cost-control methods. Implementing these programs, in addition to the well-used strategy of...

  • Applications of Modelling Studies. Nuijten, M.J.C.; Starzewski, J. // PharmacoEconomics;1998, Vol. 13 Issue 3, p289 

    There is increasing use of economic evaluation to support decision-makers in health services for allocation of scarce healthcare resources. However, information necessary for economic evaluations cannot always be derived from well-conducted prospective clinical studies, and decision-analytical...

  • Costs in rheumatology: results and lessons learned from the ‘Hannover Costing Study’. Hülsemann, J. L.; Ruof, J.; Zeidler, H.; Mittendorf, T. // Rheumatology International;Jun2006, Vol. 26 Issue 8, p704 

    The objective of this study is to review the concept of the ‘Hannover Costing Study’ and to present and discuss the major insights generated during the course of the project. The costing study was performed in conjunction with a randomized controlled prospective trial assessing the...

  • Therapeutic Specificity in Disease Management Evaluation. MacStravic, Scott // Disease Management;Feb2008, Vol. 11 Issue 1, p7 

    The author reflects on the therapeutic specificity in disease management (DM) evaluation. He notes that there must be a clear connection between the cause of DM and any changes claimed as effects if any positive changes are detected after a DM intervention. He also added that the attributed...

  • Healing the Health Care System.  // Disease Management;Dec2007, Vol. 10 Issue 6, p315 

    The article offers information on the health care system. It is noted that the health care system needs to take adjustments in response to the evolution of disease management. The range of chronic diseases treated has grown to comprise conditions such as pain management and obesity, and the care...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics